ARTV
Artiva Biotherapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$9.15-6.25%
Price as of Jul 20, 2026
ARTV capital
Artiva Biotherapeutics, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.12x
- Net debt / equity
- -0.12x
- Debt / assets
- 0.10x
- Debt / EBITDA
- -0.12x
- Net debt / EBITDA
- 0.13x
Liquidity & coverage
- Current ratio
- 8.16x
- Quick ratio
- 8.16x
- Cash ratio
- 7.98x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $77.9M
Cash & dividend
- FCF / debt
- -7.81x
- Cash flow / debt
- -7.59x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.